BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Iyer KR, Revie NM, Fu C, Robbins N, Cowen LE. Treatment strategies for cryptococcal infection: challenges, advances and future outlook. Nat Rev Microbiol 2021;19:454-66. [PMID: 33558691 DOI: 10.1038/s41579-021-00511-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 40] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Li H, Han X, Du W, Meng Y, Li Y, Sun T, Liang Q, Li C, Suo C, Gao X, Qiu Y, Tian W, An M, Zhang H, Fu Y, Li X, Lan T, Yang S, Zhang Z, Geng W, Ding C, Shang H. Comparative miRNA transcriptomics of macaques and mice reveals MYOC is an inhibitor for Cryptococcus neoformans invasion into the brain. Emerg Microbes Infect 2022;11:1572-85. [PMID: 35621025 DOI: 10.1080/22221751.2022.2081619] [Reference Citation Analysis]
2 Després PC, Cisneros AF, Alexander EMM, Sonigara R, Gagné-Thivierge C, Dubé AK, Landry CR. Asymmetrical dose responses shape the evolutionary trade-off between antifungal resistance and nutrient use. Nat Ecol Evol 2022. [PMID: 36050399 DOI: 10.1038/s41559-022-01846-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Wang WJ, Liu CC, Li YT, Li MQ, Fu YT, Li XC, Jie-Kang, Qian WD. Antifungal and Antibiofilm In Vitro Activities of Ursolic Acid on Cryptococcus neoformans. Curr Microbiol 2022;79:293. [PMID: 35972650 DOI: 10.1007/s00284-022-02992-5] [Reference Citation Analysis]
4 Tharappel AM, Li Z, Zhu YC, Wu X, Chaturvedi S, Zhang QY, Li H. Calcimycin Inhibits Cryptococcus neoformans In Vitro and In Vivo by Targeting the Prp8 Intein Splicing. ACS Infect Dis 2022. [PMID: 35948057 DOI: 10.1021/acsinfecdis.2c00137] [Reference Citation Analysis]
5 Li L, Wu H, Zhu S, Ji Z, Chi X, Xie F, Hao Y, Lu H, Yang F, Yan L, Zhang D, Jiang Y, Ni T. Discovery of Novel 7-Hydroxy-5-oxo-4,5-dihydrothieno[3,2-b]pyridine-6-carboxamide Derivatives with Potent and Selective Antifungal Activity against Cryptococcus Species. J Med Chem 2022. [PMID: 35922963 DOI: 10.1021/acs.jmedchem.2c00794] [Reference Citation Analysis]
6 Ishibashi Y. Functions and applications of glycolipid-hydrolyzing microbial glycosidases. Biosci Biotechnol Biochem 2022;86:974-84. [PMID: 35675217 DOI: 10.1093/bbb/zbac089] [Reference Citation Analysis]
7 Kassaza K, Wasswa F, Nielsen K, Bazira J. Cryptococcus neoformans Genotypic Diversity and Disease Outcome among HIV Patients in Africa. J Fungi (Basel) 2022;8:734. [PMID: 35887489 DOI: 10.3390/jof8070734] [Reference Citation Analysis]
8 Jampilek J. Novel avenues for identification of new antifungal drugs and current challenges. Expert Opin Drug Discov 2022. [PMID: 35787715 DOI: 10.1080/17460441.2022.2097659] [Reference Citation Analysis]
9 Travi BL. Current status of antihistamine drugs repurposing for infectious diseases. Medicine in Drug Discovery 2022. [DOI: 10.1016/j.medidd.2022.100140] [Reference Citation Analysis]
10 Revie NM, Iyer KR, Maxson ME, Zhang J, Yan S, Fernandes CM, Meyer KJ, Chen X, Skulska I, Fogal M, Sanchez H, Hossain S, Li S, Yashiroda Y, Hirano H, Yoshida M, Osada H, Boone C, Shapiro RS, Andes DR, Wright GD, Nodwell JR, Del Poeta M, Burke MD, Whitesell L, Robbins N, Cowen LE. Targeting fungal membrane homeostasis with imidazopyrazoindoles impairs azole resistance and biofilm formation. Nat Commun 2022;13:3634. [PMID: 35752611 DOI: 10.1038/s41467-022-31308-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Diniz-Lima I, da Fonseca LM, Dos Reis JS, Rodrigues da Costa Santos MA, da Costa KM, do Nascimento Santos CA, Barcelos PM, Guimarães-Pinto K, Filardy AA, Freire-de-Lima ME, Decote-Ricardo D, Morrot A, Freire-de-Lima CG, Freire-de-Lima L. The Sweet Side of Fungal Infections: Structural Glycan Diversity and Its Importance for Pathogenic Adaptation. Medicines (Basel) 2022;9:37. [PMID: 35736250 DOI: 10.3390/medicines9060037] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
12 Wang T, Yang W, Liu Y, Li W, Wang Y, Liu N, Sheng C. Jumonji Histone Demethylase Inhibitor JIB-04 as a Broad-Spectrum Antifungal Agent. ACS Infect Dis 2022. [PMID: 35695031 DOI: 10.1021/acsinfecdis.2c00096] [Reference Citation Analysis]
13 Qian W, Li X, Liu Q, Lu J, Wang T, Zhang Q. Antifungal and Antibiofilm Efficacy of Paeonol Treatment Against Biofilms Comprising Candida albicans and/or Cryptococcus neoformans. Front Cell Infect Microbiol 2022;12:884793. [DOI: 10.3389/fcimb.2022.884793] [Reference Citation Analysis]
14 Beattie SR, Jezewski AJ, Ristow LC, Wellington M, Krysan DJ. FKS1 Is Required for Cryptococcus neoformans Fitness In Vivo: Application of Copper-Regulated Gene Expression to Mouse Models of Cryptococcosis. mSphere 2022;:e0016322. [PMID: 35506343 DOI: 10.1128/msphere.00163-22] [Reference Citation Analysis]
15 Yang W, Zhang Y, Teng H, Liu N, Sheng C, Guo Y. Role of Azole Drugs in Promoting Fungal Cell Autophagy Revealed by an NIR Fluorescence-Based Theranostic Probe. Anal Chem 2022. [PMID: 35503259 DOI: 10.1021/acs.analchem.2c00859] [Reference Citation Analysis]
16 Wang F, Wang Y, He J, Cheng Z, Wu S, Wang M, Niu T. Clinical Characteristics and Risk Factors for Mortality in Cryptococcal Meningitis: Evidence From a Cohort Study. Front Neurol 2022;13:779435. [DOI: 10.3389/fneur.2022.779435] [Reference Citation Analysis]
17 Azam F, Khan MA, Khan A, Ahmad S, Zofair SFF, Younus H. In silico and in vitro studies on the inhibition of laccase activity by Ellagic acid: Implications in drug designing for the treatment of Cryptococcal infections. Int J Biol Macromol 2022;209:642-54. [PMID: 35421416 DOI: 10.1016/j.ijbiomac.2022.04.060] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
18 Garcia-Villa M, Gonzalez-Lara A, Rodriguez-Leyva I. Cryptococcal meningitis due to Cryptococcus gattii in an immunocompetent patient: uncommon presentation of a thunderclap headache. BMJ Case Rep 2022;15:e246158. [PMID: 35379676 DOI: 10.1136/bcr-2021-246158] [Reference Citation Analysis]
19 Lizarazo J, Castañeda E. Central Nervous System Cryptococcosis due to Cryptococcus gattii in the Tropics. Curr Trop Med Rep. [DOI: 10.1007/s40475-022-00253-w] [Reference Citation Analysis]
20 Li W, Yun Z, Ji C, Tu J, Yang W, Li J, Liu N, Sheng C. Discovery of Novel Sertraline Derivatives as Potent Anti- Cryptococcus Agents. J Med Chem . [DOI: 10.1021/acs.jmedchem.1c01845] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
21 Freitas I, Salazar T, Rodrigues P, Vilela M, Duarte A. An Uncommon Presentation of Cryptococcal Meningoencephalitis. Cureus. [DOI: 10.7759/cureus.21984] [Reference Citation Analysis]
22 Han LT, Wu YJ, Liu TB. The F-Box Protein Fbp1 Regulates Virulence of Cryptococcus neoformans Through the Putative Zinc-Binding Protein Zbp1. Front Cell Infect Microbiol 2021;11:794661. [PMID: 35024357 DOI: 10.3389/fcimb.2021.794661] [Reference Citation Analysis]
23 Akhtar N, Khurshid Wani A, Kant Tripathi S, Prakash A, Amin-ul Mannan M. The role of SARS-CoV-2 immunosuppression and the therapy used to manage COVID-19 disease in the emergence of opportunistic fungal infections: A review. Current Research in Biotechnology 2022;4:337-49. [DOI: 10.1016/j.crbiot.2022.08.001] [Reference Citation Analysis]
24 Almada S, Maia LB, Waerenborgh JC, Vieira BJC, Mira NP, R. Silva E, Cerqueira F, Pinto E, Alves LG. Cyclam-based iron( iii ) and copper( ii ) complexes: synthesis, characterization and application as antifungal agents. New J Chem . [DOI: 10.1039/d2nj03161b] [Reference Citation Analysis]
25 Hurt WJ, Harrison TS, Molloy SF, Bicanic TA. Combination Therapy for HIV-Associated Cryptococcal Meningitis-A Success Story. J Fungi (Basel) 2021;7:1098. [PMID: 34947080 DOI: 10.3390/jof7121098] [Reference Citation Analysis]
26 Baker RP, Chrissian C, Stark RE, Casadevall A. Cryptococcus neoformans melanization incorporates multiple catecholamines to produce polytypic melanin. J Biol Chem 2021;:101519. [PMID: 34942148 DOI: 10.1016/j.jbc.2021.101519] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
27 Huang Y, Zou J, Zhang KM, Li H, Hu DY, Liao WQ, Zhang L, Pan WH. Prediction of hospital discharge outcome from changes in cerebrospinal fluid/serum albumin quotient and cerebrospinal fluid lactate dehydrogenase in patients with cryptococcal meningitis. Future Microbiol 2021. [PMID: 34905957 DOI: 10.2217/fmb-2021-0272] [Reference Citation Analysis]
28 Bastos RW, Rossato L, Goldman GH, Santos DA. Fungicide effects on human fungal pathogens: Cross-resistance to medical drugs and beyond. PLoS Pathog 2021;17:e1010073. [PMID: 34882756 DOI: 10.1371/journal.ppat.1010073] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
29 Zhao J, Sun L, Sun K, Wang T, Wang B, Yang Y, Wu C, Sun X. Development and Validation of a Radiomics Nomogram for Differentiating Pulmonary Cryptococcosis and Lung Adenocarcinoma in Solitary Pulmonary Solid Nodule. Front Oncol 2021;11:759840. [PMID: 34858836 DOI: 10.3389/fonc.2021.759840] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
30 Dhasarathan P, AlSalhi MS, Devanesan S, Subbiah J, Ranjitsingh AJA, Binsalah M, Alfuraydi AA. Drug resistance in Candida albicans isolates and related changes in the structural domain of Mdr1 protein. J Infect Public Health 2021;14:1848-53. [PMID: 34794907 DOI: 10.1016/j.jiph.2021.11.002] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
31 Yang F, Gritsenko V, Lu H, Zhen C, Gao L, Berman J, Jiang YY. Adaptation to Fluconazole via Aneuploidy Enables Cross-Adaptation to Amphotericin B and Flucytosine in Cryptococcus neoformans. Microbiol Spectr 2021;9:e0072321. [PMID: 34585947 DOI: 10.1128/Spectrum.00723-21] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
32 Chen YC, Yang Y, Zhang C, Chen HY, Chen F, Wang KJ. A Novel Antimicrobial Peptide Sparamosin26-54 From the Mud Crab Scylla paramamosain Showing Potent Antifungal Activity Against Cryptococcus neoformans. Front Microbiol 2021;12:746006. [PMID: 34690992 DOI: 10.3389/fmicb.2021.746006] [Reference Citation Analysis]
33 Fu C, Beattie SR, Jezewski AJ, Robbins N, Whitesell L, Krysan DJ, Cowen LE. Genetic analysis of Hsp90 function in Cryptococcus neoformans highlights key roles in stress tolerance and virulence. Genetics 2021:iyab164. [PMID: 34849848 DOI: 10.1093/genetics/iyab164] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
34 de Oliveira HC, Rossi SA, García-Barbazán I, Zaragoza Ó, Trevijano-Contador N. Cell Wall Integrity Pathway Involved in Morphogenesis, Virulence and Antifungal Susceptibility in Cryptococcus neoformans. J Fungi (Basel) 2021;7:831. [PMID: 34682253 DOI: 10.3390/jof7100831] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
35 Green RM, Bicker KL. Discovery and Characterization of a Rapidly Fungicidal and Minimally Toxic Peptoid against Cryptococcus neoformans. ACS Med Chem Lett 2021;12:1470-7. [PMID: 34531956 DOI: 10.1021/acsmedchemlett.1c00327] [Reference Citation Analysis]
36 Yang F, Gritsenko V, Slor Futterman Y, Gao L, Zhen C, Lu H, Jiang YY, Berman J. Tunicamycin Potentiates Antifungal Drug Tolerance via Aneuploidy in Candida albicans. mBio 2021;12:e0227221. [PMID: 34465026 DOI: 10.1128/mBio.02272-21] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
37 Lin C, Yang TY, Chan MC, Hsu KH, Huang YH, Tseng JS. Comprehensive Analysis and Risk Identification of Pulmonary Cryptococcosis in Non-HIV Patients. J Fungi (Basel) 2021;7:657. [PMID: 34436197 DOI: 10.3390/jof7080657] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
38 Aldejohann AM, Herz M, Martin R, Walther G, Kurzai O. Emergence of resistant Candida glabrata in Germany. JAC Antimicrob Resist 2021;3:dlab122. [PMID: 34377983 DOI: 10.1093/jacamr/dlab122] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
39 Holič R, Šťastný D, Griač P. Sec14 family of lipid transfer proteins in yeasts. Biochim Biophys Acta Mol Cell Biol Lipids 2021;1866:158990. [PMID: 34118432 DOI: 10.1016/j.bbalip.2021.158990] [Reference Citation Analysis]
40 Fan CL, Liu TB. The Vacuolar Morphogenesis Protein Vam6-Like Protein Vlp1 Is Required for Pathogenicity of Cryptococcus neoformans. J Fungi (Basel) 2021;7:418. [PMID: 34072011 DOI: 10.3390/jof7060418] [Cited by in F6Publishing: 3] [Reference Citation Analysis]